|
MAP3K13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.657800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.183400E-01 |
| Normal-vs-Stage2 |
1.049750E-01 |
| Normal-vs-Stage3 |
2.167000E-01 |
| Normal-vs-Stage4 |
2.145400E-01 |
| Stage1-vs-Stage2 |
2.943800E-01 |
| Stage1-vs-Stage3 |
5.635600E-01 |
| Stage1-vs-Stage4 |
6.167200E-01 |
| Stage2-vs-Stage3 |
5.660800E-01 |
| Stage2-vs-Stage4 |
6.292600E-01 |
| Stage3-vs-Stage4 |
9.577200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.162200E-01 |
| Normal-vs-AfricanAmerican |
2.037600E-01 |
| Normal-vs-Asian |
2.858200E-01 |
| Caucasian-vs-AfricanAmerican |
2.519900E-02 |
| Caucasian-vs-Asian |
8.146800E-01 |
| AfricanAmerican-vs-Asian |
4.802500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.628140E-02 |
| Normal-vs-Female |
3.908600E-01 |
| Male-vs-Female |
1.909930E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.605600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.280170E-01 |
| Normal-vs-Age(61-80Yrs) |
5.021700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.940400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.518410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.787600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.956560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.050000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.819000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.665000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.586600E-01 |
| Classical-VS-Follicular |
1.089500E-02 |
| Classical-VS-Other |
1.072360E-01 |
| Classical-VS-Normal |
6.370400E-01 |
| Tall-VS-Follicular |
3.942600E-01 |
| Tall-VS-Other |
2.062400E-01 |
| Tall-VS-Normal |
3.056200E-01 |
| Follicular-VS-Other |
4.202400E-01 |
| Follicular-VS-Normal |
2.138100E-02 |
| Other-VS-Normal |
3.576000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.620400E-02 |
| Normal-vs-N1 |
5.285000E-01 |
| N0-vs-N1 |
4.891600E-01 |
|
|
